Published in Int J Pharm on October 30, 2007
Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release (2007) 1.02
Effects of solvent deposited enhancers on transdermal permeation and their relationship with Emax. J Control Release (2009) 0.81
Hyaluronic acid abrogates ethanol-dependent inhibition of collagen biosynthesis in cultured human fibroblasts. Drug Des Devel Ther (2015) 0.79
Percutaneous penetration modifiers and formulation effects: thermal and spectral analyses. AAPS PharmSciTech (2010) 0.79
Biophysical assessment of DC iontophoresis and current density on transdermal permeation of methotrexate. Int J Pharm Investig (2011) 0.75
Structure Enhancement Relationship of Chemical Penetration Enhancers in Drug Transport across the Stratum Corneum. Pharmaceutics (2012) 0.75
Investigating transdermal delivery of vitamin D3. AAPS PharmSciTech (2015) 0.75
Mechanism of enhanced dermal permeation of 4-cyanophenol and methyl paraben from saturated aqueous solutions containing both solutes. Skin Pharmacol Physiol (2010) 0.75
Dissolving polymer microneedle patches for influenza vaccination. Nat Med (2010) 3.24
Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A (2003) 2.82
Coated microneedles for transdermal delivery. J Control Release (2006) 2.66
Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev (2012) 2.65
Effect of microneedle design on pain in human volunteers. Clin J Pain (2008) 2.48
Dissolving microneedles for transdermal drug delivery. Biomaterials (2008) 2.47
Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release (2005) 2.19
Transdermal delivery of insulin using microneedles in vivo. Pharm Res (2004) 2.07
Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol (2006) 2.02
Immediate initiation of CAPD following percutaneous catheter placement without break-in procedure. Perit Dial Int (2007) 1.95
Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech (2004) 1.91
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A (2009) 1.82
Micro-scale devices for transdermal drug delivery. Int J Pharm (2008) 1.81
Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One (2009) 1.78
Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A (2008) 1.77
Polymer microneedles for controlled-release drug delivery. Pharm Res (2006) 1.72
Coating formulations for microneedles. Pharm Res (2007) 1.63
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release (2009) 1.62
Precise microinjection into skin using hollow microneedles. J Invest Dermatol (2006) 1.51
Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater (2008) 1.49
Mechanism of fluid infusion during microneedle insertion and retraction. J Control Release (2006) 1.46
Measurement and correlation of acoustic cavitation with cellular bioeffects. Ultrasound Med Biol (2006) 1.43
Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS One (2009) 1.42
Physical parameters influencing optimization of ultrasound-mediated DNA transfection. Ultrasound Med Biol (2004) 1.37
Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis (2010) 1.36
Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses. Nat Nanotechnol (2010) 1.36
Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng (2005) 1.35
Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery. IEEE Trans Biomed Eng (2007) 1.30
Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol (2010) 1.22
Kinetics of skin resealing after insertion of microneedles in human subjects. J Control Release (2011) 1.21
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther (2009) 1.19
Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. Ultrasound Med Biol (2003) 1.19
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci U S A (2009) 1.18
Dissolving microneedle patch for transdermal delivery of human growth hormone. Small (2011) 1.17
Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technol Ther (2005) 1.17
Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine (2009) 1.16
Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep (2012) 1.14
Microinfusion using hollow microneedles. Pharm Res (2006) 1.13
Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs. J Pharm Sci (2010) 1.13
Quantification of optison bubble size and lifetime during sonication dominant role of secondary cavitation bubbles causing acoustic bioeffects. J Acoust Soc Am (2004) 1.12
The effect of heat on skin permeability. Int J Pharm (2008) 1.11
An electrically active microneedle array for electroporation. Biomed Microdevices (2010) 1.10
Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs. J Pharm Sci (2010) 1.09
A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm (2010) 1.08
Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci (2012) 1.07
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Does needle size matter? J Diabetes Sci Technol (2007) 1.05
Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release (2010) 1.05
Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. Diabetes Technol Ther (2011) 1.05
Separable arrowhead microneedles. J Control Release (2010) 1.05
Shear-induced intracellular loading of cells with molecules by controlled microfluidics. Biotechnol Bioeng (2008) 1.04
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Stability of influenza vaccine coated onto microneedles. Biomaterials (2012) 1.04
Layer-by-layer assembly of DNA- and protein-containing films on microneedles for drug delivery to the skin. Biomacromolecules (2010) 1.03
Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res (2010) 1.03
Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res (2010) 1.03
Measles vaccination using a microneedle patch. Vaccine (2012) 1.03
Local response to microneedle-based influenza immunization in the skin. MBio (2012) 1.03
Future directions for therapeutic ultrasound. Ultrasound Med Biol (2007) 1.03
Transdermal delivery enhanced by magainin pore-forming peptide. J Control Release (2007) 1.02
Equilibrium loading of cells with macromolecules by ultrasound: effects of molecular size and acoustic energy. J Pharm Sci (2002) 1.02
Flux across [corrected] microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro. Pharm Res (2008) 1.01
Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol (2010) 1.01
Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination. J Infect Dis (2011) 1.01
Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine (2012) 1.00
Tissue electroporation: quantification and analysis of heterogeneous transport in multicellular environments. Biophys J (2004) 0.99
Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech (2010) 0.98
Bacillus Calmette-Guérin vaccination using a microneedle patch. Vaccine (2011) 0.98
Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries. J Control Release (2007) 0.98
Modeling transmembrane transport through cell membrane wounds created by acoustic cavitation. Biophys J (2008) 0.96
Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol (2011) 0.96
Effect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccine. PLoS One (2012) 0.96
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res (2004) 0.95
Changes in cell morphology due to plasma membrane wounding by acoustic cavitation. Ultrasound Med Biol (2010) 0.95
Enabling skin vaccination using new delivery technologies. Drug Deliv Transl Res (2011) 0.94
Subjects with diarrhea-predominant IBS have increased rectal permeability responsive to tryptase. Dig Dis Sci (2010) 0.93
Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater (2014) 0.92
Pocketed Microneedles for Drug Delivery to the Skin. J Phys Chem Solids (2008) 0.92
Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res (2012) 0.91
Recovery of skin barrier properties after sonication in human subjects. Ultrasound Med Biol (2009) 0.91
Rapid local anesthesia in humans using minimally invasive microneedles. Clin J Pain (2012) 0.91
Model of transient drug diffusion across cornea. J Control Release (2004) 0.90
Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release (2012) 0.90
Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomaterials (2011) 0.90
Selective removal of stratum corneum by microdermabrasion to increase skin permeability. Eur J Pharm Sci (2009) 0.90
Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine (2010) 0.89
Influence of the cell wall on intracellular delivery to algal cells by electroporation and sonication. Ultrasound Med Biol (2007) 0.89
Visualization of plasmid delivery to keratinocytes in mouse and human epidermis. Sci Rep (2011) 0.89
The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal. Pharm Res (2010) 0.89
Risk factors for rhabdomyolysis following doxylamine overdose. Hum Exp Toxicol (2007) 0.89
Can ultrasound enable efficient intracellular uptake of molecules? A retrospective literature review and analysis. Ultrasound Med Biol (2012) 0.88
Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. Eur J Pharm Biopharm (2012) 0.88
Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest Ophthalmol Vis Sci (2008) 0.88